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Tuberculosis - Massachusetts 
In 2018, 200 cases (incidence rate 2.9 per 100,000 residents*) of tuberculosis 
(TB) disease were reported to, and verified by, the Massachusetts Department of 
Public Health. The Massachusetts case rate remains similar to the United States 
(U.S.) national case rate (2.8 per 100,000 residents)†.  The number of cases in 
2018 represents a 4.8% decrease from the previous year. The multi-year trend 
continues to show an overall decline. Comparing the most recent five-year period 
(2014-2018) with the previous period (2009-2013), the average number of cases 
declined 13%, from 229 to 198 per year. Health disparities continue to be 
prominent, with populations born outside the U.S. at increased risk for TB. State 
and local prevention efforts continue to focus on these high-risk populations, as 
well as contacts of TB cases. 
 
Race/Ethnicity  
Racial/ethnic minorities are disproportionately affected by TB; 85.5% of active TB 
disease in 2018 was diagnosed in members of minority groups. The TB case rate 
per 100,000 residents in 2018 was 26.6 among Asian non-Hispanic residents, 
11.7 among black non-Hispanic residents, and 4.3 among Hispanic residents; 
compared with 0.6 among white non-Hispanic residents. Compared with white 
residents, the relative risk for being diagnosed with TB in 2018 was approximately 
44.3 times higher among Asian (95% CI 43.9, 44.7), 19.5 times higher among 
Black (95% CI 19.0, 20.0), and 7.2 times higher among Hispanic (95% CI 6.7, 7.8) 
residents. 
  
Higher Risk Groups 
Non-U.S. Born (persons born outside the United States and territories): Among 
200 cases of TB in 2018, 172 (86%) were reported in non-U.S. born persons. 107 
(62%) cases were in persons born in one of nine countries: India (26, 15%), China 
(20, 12%), Haiti (14, 8%), Vietnam (14, 8%), Brazil (8, 5%), Cambodia (8, 5%), 
Nepal (6, 3%), Cape Verde (6, 3%), and Morocco (5, 3%). The remaining 65 
cases (38%) occurred in persons born in 35 additional countries. 
 
Children <15 Years of Age: In 2018, seven cases of TB were diagnosed in 
children under 15 years of age (3.5% of cases, incidence rate <1/100,000 children 
under 15 years old). Five of the seven children (71.4%) were born in the U.S.    
 
Incarcerated in Prison/Jail: Five cases of TB were diagnosed in correctional 
facility inmates in 2018.  
 
Homeless: Of the 200 cases of TB reported in 2018, 3 (1.5%) were in persons 
experiencing homelessness within the previous year. Two (67%) were U.S.-born 
individuals. 
  
HIV Co-infected (preliminary): Thirteen persons (6.5%) diagnosed with TB in 2018 
were known to be co-infected with human immunodeficiency virus (HIV). 
 
Drug Resistance 
In 2018, 157 (78.5%) of the 200 TB cases were bacteriologically confirmed by 
positive culture for Mycobacterium tuberculosis, and had isolates available for 
drug susceptibility testing. Resistance testing was successfully completed on 154 
(98%) of the 157 isolates. 
 
Resistance to one or more anti-TB drugs was detected in 31 (15.5%) of the 154 
isolates. Resistance to isoniazid (INH), either alone or in combination with other 
agents, was seen in 9.5%. With MDR-TB increasing worldwide, MDR-TB in 
Massachusetts is carefully monitored and remains a priority of the TB program. 
Characteristics of TB Cases 2018 
(N=200) 
Demographics                              # (%) 
Sex 
Male     
Female    
 
113 (56.5%) 
87 (43.5%) 
Race Ethnicity  
White, non-Hispanic  
Black, non-Hispanic  
Hispanic  
Asian 
 
29 (14.5%) 
 51 (25.5%) 
27 (13.5%) 
 93 (46.5%) 
Origin of Birth  
U.S. born             
Non-U.S. born  
Unknown 
 
28 (14%)    
172 (86%) 
0 (0%) 
Age (years) 
<5 
 5-14 
15-19 
20-24 
25-44     
45-64     
65+  
 
4 (2.0%) 
3 (1.5%) 
3 (1.5%) 
  15 (7.5%) 
72 (36.0%) 
52 (26.0%) 
51 (25.5%) 
Clinical Presentation (N=200) 
Primary Site of Disease  
Pulmonary             
Extra-pulmonary  
Both             
    
120 (60.0%) 
61 (30.5%) 
19 (9.5%) 
Chest Radiography 
Cavitary disease only           
Miliary disease only 
Cavitary and miliary  
Non-cavitary disease only     
Normal findings 
Not reported 
 
30 (15%) 
8 (4%) 
1 (0.5%) 
125 (62.5%) 
14 (7%) 
22 (11%) 
Higher Risk Groups+ (N=200) 
Non-U.S. born  
Children <15 years of age 
Incarcerated in prison/jail 
Homeless 
Substance use* 
HIV co-infection 
172 (86.0%) 
   7 (3.5%) 
 5 (2.5%) 
3 (1.5%) 
   9 (4.5%) 
    13 (6.5%) 
Drug Resistance Culture confirmed 
cases with drug susceptibility results 
(N=154) 
Pattern   
Resistance to at least 1drug 
Resistance to at least INH 
Resistance to at least INH 
and RIF (MDR-TB) 
 
 31(15.5%) 
19 (9.5%) 
1 (0.5%) 
+ Not mutually exclusive groups 
*  Alcohol, injecting and  non-injecting drug use 
